At Symbiosis, we believe that quality and compliance are inextricably linked to patient safety. As such, it’s our key priority.
Delivering regulatory excellence is not just a point of principle; it sets Symbiosis apart. It’s how we meet client needs and build lasting relationships.
This commitment to quality and compliance is the bedrock of our reputation and our trust in the industry. We recognise that every product we make has the potential to impact countless lives … and we take this responsibility very seriously.
For good reason, the pharmaceutical industry operates a stringent regulatory framework. These regulations are designed to protect patients.
At Symbiosis, we are laser-focused on meeting all regulatory requirements. This relies on ensuring oversight of the ever-changing regulatory landscape; Symbiosis takes measures to ensure that any regulatory changes are understood, assessed and implemented as required.
Implementing quality management systems
To ensure consistent quality and compliance, Symbiosis committed to the installation of an electronic quality management system (QMS) from its inception.
This system provides a framework to manage all quality processes, from new product introduction to finished form release. These systems — and periodic upgrades (most recently in 2025) — underpin a culture of quality and compliance throughout the company.
Symbiosis follows standard processes and procedures, ensuring they are documented, consistently followed and regularly reviewed for effectiveness.
This helps us to minimise errors and ensure that our products meet all quality standards. We continuously monitor our processes and products for quality and compliance using data-driven metrics to identify areas for improvement.
This includes regular internal audits and external inspections to ensure we meet regulatory requirements and follow all relevant guidelines.
Regular review meetings are conducted with the senior management team to ensure the effectiveness of the QMS. We have also implemented a system to identify and mitigate potential risks to product quality, patient safety and regulatory compliance.
This proactive approach helps us to prevent issues before they arise and ensure our products are consistently safe and effective.
Delivering therapies with unwavering commitment to quality
Ultimately, the importance of quality and compliance comes down to patient welfare. Patients rely on pharmaceutical products to treat and manage their health, and they deserve to have confidence in the safety and efficacy of these products.
By prioritising quality and compliance, we ensure that our products are safe and reliable. Compliance with EU GMP Annex 1 is at the core of our operations, thereby ensuring a holistic approach to sterility assurance — with our contamination control strategy (CCS) embedded within our QMS.
Our rigorous testing and quality control (QC) procedures ensure that our products are free from contaminants and impurities and meet the defined specifications.
We strictly adhere to GMP (Good Manufacturing Practice) to ensure that the quality of our products meets the registered parameters and that they are fit for their intended therapeutic purpose.
Delivering high-quality products that meet regulatory requirements reinforces our commitment to patient safety, which builds trust with our clients and their end users.
